The distressed biotech firm, NovaGen Therapeutics, faced severe fiscal difficulties stemming from disappointing clinical trials and mounting debt. Their internal team lacked the experience to navigate the https://alvinsyft748520.blognody.com/50204511/biotech-cfo-services-a-case-study-in-financial-restructuring